Search Results

There are 12153 results for: content related to: Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations

  1. You have full text access to this OnlineOpen article
    Two-year, randomized, controlled study of safinamide as add-on to levodopa in mid to late Parkinson's disease

    Movement Disorders

    Volume 29, Issue 10, September 2014, Pages: 1273–1280, Rupam Borgohain, Jozsef Szasz, Paolo Stanzione, Chandrashekhar Meshram, Mohit H. Bhatt, Dana Chirilineau, Fabrizio Stocchi, Valentina Lucini, Rodolfo Giuliani, Emma Forrest, Patricia Rice, Ravi Anand and the Study 018 Investigators

    Version of Record online : 10 JUL 2014, DOI: 10.1002/mds.25961

  2. Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials

    Movement Disorders

    Volume 28, Issue 2, February 2013, Pages: 131–144, Lorraine V. Kalia, Jonathan M. Brotchie and Susan H. Fox

    Version of Record online : 5 DEC 2012, DOI: 10.1002/mds.25273

  3. New treatments for levodopa-induced motor complications

    Movement Disorders

    Volume 30, Issue 11, 15 September 2015, Pages: 1451–1460, Olivier Rascol, Santiago Perez-Lloret and Joaquim J Ferreira

    Version of Record online : 21 AUG 2015, DOI: 10.1002/mds.26362

  4. The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations

    Movement Disorders

    Volume 31, Issue 8, August 2016, Pages: 1080–1094, Raul Martínez-Fernández, Emmanuelle Schmitt, Pablo Martinez-Martin and Paul Krack

    Version of Record online : 19 JUL 2016, DOI: 10.1002/mds.26731

  5. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  6. You have free access to this content
    Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy

    Movement Disorders

    Volume 32, Issue 9, September 2017, Pages: 1264–1310, J.A. Obeso, M. Stamelou, C.G. Goetz, W. Poewe, A.E. Lang, D. Weintraub, D. Burn, G.M. Halliday, E. Bezard, S. Przedborski, S. Lehericy, D.J. Brooks, J.C. Rothwell, M. Hallett, M.R. DeLong, C. Marras, C.M. Tanner, G.W. Ross, J.W. Langston, C. Klein, V. Bonifati, J. Jankovic, A.M. Lozano, G. Deuschl, H. Bergman, E. Tolosa, M. Rodriguez-Violante, S. Fahn, R.B. Postuma, D. Berg, K. Marek, D.G. Standaert, D.J. Surmeier, C.W. Olanow, J.H. Kordower, P. Calabresi, A.H.V. Schapira and A.J. Stoessl

    Version of Record online : 9 SEP 2017, DOI: 10.1002/mds.27115

  7. Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

    Movement Disorders

    Volume 32, Issue 7, July 2017, Pages: 955–971, Jennifer L. Whitwell, Günter U. Höglinger, Angelo Antonini, Yvette Bordelon, Adam L. Boxer, Carlo Colosimo, Thilo van Eimeren, Lawrence I. Golbe, Jan Kassubek, Carolin Kurz, Irene Litvan, Alexander Pantelyat, Gil Rabinovici, Gesine Respondek, Axel Rominger, James B. Rowe, Maria Stamelou, Keith A. Josephs and for the Movement Disorder Society-endorsed PSP Study Group

    Version of Record online : 13 MAY 2017, DOI: 10.1002/mds.27038

  8. The focal dystonias: Current views and challenges for future research

    Movement Disorders

    Volume 28, Issue 7, 15 June 2013, Pages: 926–943, H. A. Jinnah, Alfredo Berardelli, Cynthia Comella, Giovanni DeFazio, Mahlon R. DeLong, Stewart Factor, Wendy R. Galpern, Mark Hallett, Christy L. Ludlow, Joel S. Perlmutter, Ami R. Rosen and for the Dystonia Coalition Investigators

    Version of Record online : 25 JUL 2013, DOI: 10.1002/mds.25567

  9. Neuropathology of multiple system atrophy: New thoughts about pathogenesis

    Movement Disorders

    Volume 29, Issue 14, December 2014, Pages: 1720–1741, Kurt A. Jellinger

    Version of Record online : 9 OCT 2014, DOI: 10.1002/mds.26052

  10. Advances in the treatment of cognitive impairment in Parkinson's disease

    Movement Disorders

    Volume 30, Issue 11, 15 September 2015, Pages: 1471–1489, Jennifer G. Goldman and Daniel Weintraub

    Version of Record online : 22 AUG 2015, DOI: 10.1002/mds.26352

  11. You have free access to this content
    Current applications and limitations of surgical treatments for movement disorders

    Movement Disorders

    Volume 32, Issue 1, January 2017, Pages: 36–52, Paul Krack, Raul Martinez-Fernandez, Marta del Alamo and Jose A. Obeso

    Version of Record online : 25 JAN 2017, DOI: 10.1002/mds.26890

  12. Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease

    European Journal of Neurology

    Volume 20, Issue 2, February 2013, Pages: 271–280, A. H. V. Schapira, F. Stocchi, R. Borgohain, M. Onofrj, M. Bhatt, P. Lorenzana, V. Lucini, R. Giuliani, R. Anand and The Study 017 Investigators

    Version of Record online : 12 SEP 2012, DOI: 10.1111/j.1468-1331.2012.03840.x

  13. Improving l-dopa therapy: The development of enzyme inhibitors

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 103–113, Oscar S. Gershanik

    Version of Record online : 21 OCT 2014, DOI: 10.1002/mds.26050

  14. Effects of ketoconazole treatment on the pharmacokinetics of safinamide and its plasma metabolites in healthy adult subjects

    Biopharmaceutics & Drug Disposition

    Volume 33, Issue 9, December 2012, Pages: 550–559, Sonja Krösser, Anne Marquet, Dieter Gallemann, Peter Wolna, Nicolas Fauchoux, Robert Hermann and Andreas Johne

    Version of Record online : 19 NOV 2012, DOI: 10.1002/bdd.1822

  15. Biomarkers for dementia and mild cognitive impairment in Parkinson's disease

    Movement Disorders

    Volume 31, Issue 6, June 2016, Pages: 861–881, Manuel Delgado-Alvarado, Belén Gago, Irene Navalpotro-Gomez, Haritz Jiménez-Urbieta and María C. Rodriguez-Oroz

    Version of Record online : 19 MAY 2016, DOI: 10.1002/mds.26662

  16. Nomenclature of genetic movement disorders: Recommendations of the international Parkinson and movement disorder society task force

    Movement Disorders

    Volume 31, Issue 4, April 2016, Pages: 436–457, Connie Marras, Anthony Lang, Bart P. van de Warrenburg, Carolyn M. Sue, Sarah J. Tabrizi, Lars Bertram, Saadet Mercimek-Mahmutoglu, Darius Ebrahimi-Fakhari, Thomas T. Warner, Alexandra Durr, Birgit Assmann, Katja Lohmann, Vladimir Kostic and Christine Klein

    Version of Record online : 15 APR 2016, DOI: 10.1002/mds.26527

  17. A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients

    Movement Disorders

    Volume 27, Issue 1, January 2012, Pages: 106–112, Fabrizio Stocchi, Rupam Borgohain, Marco Onofrj, Anthony H.V. Schapira, Mohit Bhatt, Valentina Lucini, Rodolfo Giuliani, Ravi Anand and for the Study 015 Investigators

    Version of Record online : 12 SEP 2011, DOI: 10.1002/mds.23954

  18. Absolute Bioavailability and Effect of Food on the Disposition of Safinamide Immediate Release Tablets in Healthy Adult Subjects

    Clinical Pharmacology in Drug Development

    Volume 2, Issue 1, January 2013, Pages: 79–89, Annick Seithel-Keuth, Andreas Johne, Achim Freisleben, Katrin Kupas, Michael Lissy and Sonja Krösser

    Version of Record online : 22 FEB 2013, DOI: 10.1002/cpdd.2

  19. You have free access to this content
    Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson's disease

    Movement Disorders

    Volume 32, Issue 3, March 2017, Pages: 346–363, Maria Pia Giannoccaro, Chiara La Morgia, Giovanni Rizzo and Valerio Carelli

    Version of Record online : 2 MAR 2017, DOI: 10.1002/mds.26966

  20. Animal models of Huntington's disease for translation to the clinic: Best practices

    Movement Disorders

    Volume 29, Issue 11, 15 September 2014, Pages: 1375–1390, Liliana Menalled and Daniela Brunner

    Version of Record online : 12 SEP 2014, DOI: 10.1002/mds.26006